Development Level

Tchem 3 | 1,890
Tclin 2 | 602
Tbio 1 | 10,625

IMPC Term

abnormal behavior 1 | 226
abnormal femur morphology 1 | 14

Disease

Breast cancer 4 | 3,094
Cancer 4 | 2,346
Carcinoma 4 | 2,147
osteosarcoma 4 | 7,933
ovarian cancer 4 | 8,484
psoriasis 4 | 6,685
astrocytic glioma 3 | 2,241
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
malignant mesothelioma 3 | 3,162
medulloblastoma, large-cell 3 | 6,234
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,795
pituitary cancer 3 | 1,972
Arthritis 2 | 248
Atopic dermatitis 2 | 944
Autistic Disorder 2 | 320
Blastic phase chronic myeloid leukemia 2 | 58
Chronic Myelocytic Leukemia Accelerated Phase 2 | 59
Chronic phase chronic myeloid leukemia 2 | 45
Huntington's disease 2 | 72
Liver carcinoma 2 | 217
Mammary Neoplasms 2 | 410
Neoplasm Invasiveness 2 | 127
Philadelphia Chromosome Positive Chronic Myelocytic Leukemia 2 | 45
Philadelphia chromosome-positive acute lymphoblastic leukemia 2 | 47
Rosacea 2 | 18
Withdrawal disorder 2 | 19
atypical teratoid / rhabdoid tumor 2 | 4,369
diabetes mellitus 2 | 1,663
ductal carcinoma in situ 2 | 1,745
glioblastoma 2 | 5,572
group 4 medulloblastoma 2 | 1,875
lung cancer 2 | 4,466
non-small cell lung cancer 2 | 2,798
oligodendroglioma 2 | 2,849
Acne 1 | 20
Agammaglobulinemia 1 | 24
Alcohol dependence 1 | 107
Allergic conjunctivitis 1 | 25
Androgen insensitivity syndrome 1 | 11
Anxiety Disorders 1 | 37
Anxiety disorder 1 | 22
Aplastic anemia 1 | 18
Ariboflavinosis 1 | 4
Autosomal Recessive Polycystic Kidney Disease 1 | 5
Beriberi 1 | 13
COPD 1 | 113
Cardiomegaly 1 | 66
Central sleep apnea 1 | 12
Cherubism 1 | 14
Complex regional pain syndrome 1 | 12
Congenital hypoplastic anemia 1 | 8
Corneal abrasion 1 | 6
Corneal ulcer 1 | 9
Cyclitis 1 | 6
Delayed Puberty 1 | 10
Diabetic Nephropathy 1 | 37
Eating disorder 1 | 24
Epicondylitis 1 | 19
Fibromyalgia 1 | 22
Gastrointestinal system disease 1 | 50
Gestational Diabetes 1 | 17
Gynecomastia 1 | 13
Hepatitis C 1 | 90
Hereditary angioneurotic edema 1 | 3
Herpes zoster keratitis 1 | 6
Hormone receptor positive malignant neoplasm of breast 1 | 10
Hyperactive behavior 1 | 31
Hypogonadism 1 | 70
Hypogonadotropic hypogonadism 1 | 4
Hypopituitarism 1 | 36
Hypospadias 1 | 65
Hypospadias 1, X-Linked 1 | 2
Insulin Resistance 1 | 48
Iridocyclitis 1 | 12
Iritis 1 | 9
Irritable bowel syndrome 1 | 59
Kidney cancer 1 | 118
Klinefelter's syndrome 1 | 59
Kummell's disease 1 | 4
Malignant tumor of prostate 1 | 11
Metastatic Prostate Carcinoma 1 | 18
Muscular atrophy 1 | 67
Neoplasm Recurrence, Local 1 | 23
Noonan Syndrome 1 | 33
Osteopetrosis 1 | 40
Post-Op Ocular Inflammation 1 | 10
Prostatic Intraepithelial Neoplasias 1 | 11
Prostatic hypertrophy 1 | 9
Pseudohermaphroditism 1 | 16
Punctate Epithelial Keratopathy 1 | 6
Rhinitis 1 | 46
Spinocerebellar ataxia type 23 1 | 2
Squamous cell carcinoma 1 | 94
Testicular cancer 1 | 24
Uveitis 1 | 103
Wernicke encephalopathy 1 | 12
chronic kidney disease 1 | 90
interstitial lung disease 1 | 291

Tissue

Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Nervous System 6 | 18,561
Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Kinase 3 | 634
Non-IDG 2 | 11,971
Nuclear Receptor 1 | 48

Grant Application

5R01DK052659-06 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Sorbin and SH3 domain-containing protein 1 SORBS1 Tbio Non-IDG -1.60755 39.5 196
Androgen receptor AR Tclin Nuclear Receptor -3.78107 6683.7 1366
Focal adhesion kinase 1 PTK2 Tchem Kinase -3.01237 956.9 1799
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Proto-oncogene tyrosine-protein kinase Src SRC Tclin Kinase -3.97208 8801.0 1257
Ephrin type-A receptor 3 EPHA3 Tchem Kinase -2.35281 237.0 306